Mar. 6 at 4:37 PM
MiniMed Group (NASDAQ:
$MMED), Medtronic’s diabetes spin‑off, has priced its IPO at
$20 per share for 28 million shares to raise
$560M, and will start trading on the Nasdaq Global Select Market tomorrow under ticker MMED, with Medtronic retaining roughly 90% ownership post‑offering.
https://prismmarketview.com/minimed-prices-initial-public-offering-as-medtronic-diabetes-unit-prepares-to-trade-independently/